Outlook Therapeutics Inc (NASDAQ:OTLK)

Delayed Data
As of Jul 02
 +0.01 / +0.78%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Outlook Therapeutics Inc have a median target of 6.00, with a high estimate of 9.00 and a low estimate of 3.25. The median estimate represents a +365.12% increase from the last price of 1.29.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Outlook Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.62%
Growthannually 48.55%


Growthquarterly --
Growthannually -96.01%
Key to the earnings and sales forecast charts.